Subcommittee on Neurological Disease committee   was clear in saying that let's not just do an interesting academic exercise, that we do have to test. Why did the MS Society's announcement of research spending a few days ago aim exclusively at finding a statistical association of CCSVI in MS patients and not at allocating a single

Subcommittee on Neurological Disease committee  The MS Society heard from our clients in November when Dr. Zamboni's work was on the public stage. We expedited a process for a research grant, which we normally don't do at the MS Society, because we heard the need for CCSVI and MS research. At that stage, we crafted a request

Subcommittee on Neurological Disease committee   is related to MS, but how much is actually allocated to CCSVI.

Multiple Sclerosis  Mr. Speaker, last night the House came together to support MS patients from across the country, fighting for diagnosis and treatment of CCSVI, or narrowed veins. This morning, the Subcommittee on Neurological Disease heard compelling testimony from Dr. Zamboni, who first

Health committee   know it's $16 million to CIHR. That's for everything, as you rightly point out. We also know that the money is for MS in general. We have asked for this to be specifically $10 million. The $10 million request that came from the MS Society was for CCSVI. What we have been advocating

Health committee   trials, juvenile diabetes being a very important candidate. Out of that $16 million, I don't know how much is for MS, and out of that for MS, we aren't sure really whether it's for CCSVI. So I think that the request by the MS Society for $10 million for research.... The patients

Health committee  And hopefully the majority of that will go to MS CCSVI treatment, but you can't pick an arbitrary--

Questions on the Order Paper  With respect to chronic cerebrospinal venous insufficiency (CCSVI), the “liberation” procedure, and multiple sclerosis (MS): (a) does Health Canada recognize the International Union of Phebology (IUP), and is Canada a member; (b) does Health Canada recognize the IUP’s Consensus

Questions on the Order Paper  Mr. Speaker, with respect to Health Canada, questions related to the treatment and diagnosis of chronic cerebro-spinal venous insufficiency, CCSVI, are of a clinical nature and are best directed toward the provinces and territories and their respective physician associations

Multiple Sclerosis  Mr. Speaker, today people living with MS are protesting across this country, including on Parliament Hill, for clinical trials for the new liberation procedure for chronic cerebrospinal venous insufficiency or CCSVI. Over 1,500 liberation procedures have been performed

Health  Mr. Speaker, our government understands the difficulties of Canadians living with multiple sclerosis. Can the Minister of Health share with the House her latest efforts with respect to research on the possibilities associated with CCSVI?

Petitions  Mr. Speaker, this petition calls for an act for equal access to CCSVI treatment for Canadians living with multiple sclerosis. We all know family and friends who are affected by this ravaging disease and the size of this petition made it possible for people to actually sign

Petitions   to obtain advice and evidence-based information about CCSVI treatment and take a lead role on the basis of this evidence in encouraging the swift adoption of the procedure in the territories and provinces. While l know that House rules do not allow me to explicitly endorse petitions, I

Petitions   Agency for Drugs and Technologies in Health, to obtain advice and evidence-based information about the effectiveness of chronic CCSVI treatment without delay, and to take a leading role on the basis of the evidence in encouraging the swift adoption of the procedure in the territories

Petitions  Mr. Speaker, I am pleased to present a petition regarding chronic cerebrospinal venous insufficiency, CCSVI, for which the testing and treatment is safe, inexpensive and effective. The treatment of CCSVI is veinography followed by balloon venoplasty, a routine treatment